Drug firm Glenmark Pharmaceuticals today announced it plans to raise around $ 200 million (around INR 1,341 crore) by issuing dollar denominated non-convertible unsecured bonds to repay debt. In a filing to BSE on 18th July 2016, Glenmark Pharmaceuticals Ltd Bombay Stock Exchange -1.28 per cent has decided to tap into the International Bond market and is planning to raise around $ 200 millio